Alzamend Trials Novel Lithium Treatment
The company is testing a new organic lithium salt designed for better brain delivery and less toxicity. Results from a Phase 1/2A trial were presented by researchers sponsored by A…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The company is testing a new organic lithium salt designed for better brain delivery and less toxicity. Results from a Phase 1/2A trial were presented by researchers sponsored by A…
The U.S. FDA has approved Emcitate (tiratricol) to treat peripheral thyrotoxicosis, the first FDA-approved therapy for MCT8 Deficiency. The condition causes symptoms such as rapid …
FDA is carefully reviewing its Premarket Tobacco Product Application rule and judicial developments, including a federal lawsuit filed in the Northern District of Texas challenging…
Boladale Lawal & Co. CEO signed a letter of agreement with the SEC supporting Origin Tea's regulatory filing, highlighting the company's corporate governance.
Glucotrack amended a warrant to include a 20% floor price for share purchases relative to Nasdaq requirements. This change aims to protect the holder against excessive reductions t…
NeOnc will meet with FDA in November to review its Phase 2 design for the gastric cancer drug NEO212. The company reported encouraging clinical data from the previous Phase 1 trial…
Ernst & Young LLP, the public accounting firm, reviewed McCormick & Co's Form 8-K dated September 28, 2026, and agreed with its first three paragraphs.
Marwynn Holdings filed its Third Amended and Restated Bylaws and its exhibits to the SEC. This corporate governance document outlines the management structure for the Company. The …
CapsoVision announced FDA clearance for its AI Highlights tool on September 25, aimed at reducing physician review time for small bowel capsule endoscopy studies. The feature integ…
Kodiak reported positive primary endpoint results for both Zenkuda in wet AMD and tabirafusp-ted, establishing a potential first-line benchmark for Zenkuda; the company plans to fi…
Greenland Energy Company confirmed completion of field approvals for its government-mandated Jameson Land environmental baseline program, a requirement for future drilling.
TransCode Therapeutics reported positive Phase 1a clinical data for its anti-miR-10b candidate TTX-MC138 in advanced solid tumors, with a 71.4% stable disease rate and notable dura…
Fate Therapeutics announced a $15 million CIRM grant for its Phase 2 lupus nephritis trial, advancing its FT819 off-the-shelf CAR T-cell therapy. The funding is intended to broaden…
Keros Therapeutics has dosed the first patient in a Phase 2 trial of Rinvatercept targeting Duchenne muscular dystrophy. As a clinical-stage biopharmaceutical company with no curre…
Flutter Entertainment halted betting operations in Brazil following a government executive order, a move expected to cut 2026 revenue and EBITDA by approximately $70m and $20m resp…
Moleculin announced a peer-reviewed study showing no cardiotoxicity with Annamycin at cumulative doses exceeding traditional anthracycline limits, potentially validating its contin…
Hepion Pharmaceuticals reported in its Form 8-K that independent auditors Grassi & Co. have agreed with the financial statements contained in the filing. This confirmation provides…
Flash Sports commenced trading on OTCID under FLZH and has filed an application with OTCQB. Additionally, the company announced a cancelled annual meeting and the rescheduling of a…
Federal Reserve Board has approved the application by Peoples Bancorp Inc.
Southland Holdings received notification of noncompliance due to a $248.2M shareholder deficit and net losses over five years. The company must file a plan by Oct 23, 2026, to avoi…